| 000 | 01872 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516155931.0 | ||
| 264 | 0 | _c20141008 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1442-2042 | ||
| 024 | 7 |
_a10.1111/iju.12205 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVeeratterapillay, Rajan | |
| 245 | 0 | 0 |
_aDiscontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity. _h[electronic resource] |
| 260 |
_bInternational journal of urology : official journal of the Japanese Urological Association _cFeb 2014 |
||
| 300 |
_a175-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Intravesical |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeuromuscular Agents _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrinary Bladder, Neurogenic _xdrug therapy |
| 650 | 0 | 4 |
_aUrinary Bladder, Overactive _xdrug therapy |
| 650 | 0 | 4 | _aUrinary Catheterization |
| 650 | 0 | 4 |
_aUrinary Tract Infections _xetiology |
| 650 | 0 | 4 |
_aUrodynamics _xdrug effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHarding, Chris | |
| 700 | 1 | _aTeo, Luke | |
| 700 | 1 | _aVasdev, Nikhil | |
| 700 | 1 | _aAbroaf, Ahmed | |
| 700 | 1 | _aDorkin, Trevor J | |
| 700 | 1 | _aPickard, Robert S | |
| 700 | 1 | _aHasan, Tahseen | |
| 700 | 1 | _aThorpe, Andrew C | |
| 773 | 0 |
_tInternational journal of urology : official journal of the Japanese Urological Association _gvol. 21 _gno. 2 _gp. 175-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/iju.12205 _zAvailable from publisher's website |
| 999 |
_c22884945 _d22884945 |
||